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KESAN PORTLAND SIMEN-KITOSAN KE ATAS PEMBEZAAN 
DENTINOGENIK DAN OSTEOGENIK DALAM SEL STEM DARI GIGI 
SUSU MANUSIA YANG TERLUPAS 
ABSTRAK 
Mineral trioksida agregat (MTA) adalah biomaterial endodontik yang ideal 
untuk masa sekarang tetapi penggunaanya dibatasi oleh kos yang mahal, masa 
penetapan yang lama dan kesan toksiknya kepada sel. Untuk mengatasi masalah ini, 
penemuan dan pengembangan biomaterial baru sangat diperlukan. Oleh sebab itu, 
tujuan kajian ini adalah untuk menentukan kesan Portland simen-kitosan (APC-
CHT) ke atas pembezaan dentinogenik dan osteogenik dalam sel induk dari gigi 
gugur manusia (SHED). APC-CHT telah dihasilkan 1 minggu sebelum 14 hari 
rawatan ke atas SHED. Morfologi sel dikaji menggunakan mikroskop terbalik. 
SHED menunjukkan peralihan fenotip dari morfologi seperti fibroblast kepada 
morfologi spindle bermula dari hari 7 hingga hari 14. Kepekatan protein setiap 
kumpulan yang diperolehi oleh ujian Bradford menunjukkan peningkatan 
bilangan protein dari hari 3 hingga hari 14. Kepekatan protein tertinggi adalah 
16.89 mg / ml, yang berada dalam kumpulan 4 (APC-2,5% CHT). Saiz protein 
dalam kajian ini iaitu OCN, GAPDH, ALP, DMP-1, MEPE, OPN dan DSPP 
dinilai menggunakan SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE). 
Keamatan jalur tertinggi diperhatikan pada hari 14 dalam kumpulan 3 
(APC-1,25% CHT) dan 4 (APC-2,5% CHT). Analisis peblotan Western juga 
menunjukkan kemunculan jalur yang jelas pada hari ke-14 pada kumpulan 3 
dan 4. Kesimpulannya, APC-CHT menunjukkan kesan yang baik terhadap pembezaan 
dentinogenik / osteogenik dalam SHED dan berpotensi tinggi untuk digunakan 
sebagai bahan alternatif dalam aplikasi pergigian. 
xii 
EFFECT OF ACCELERATED PORTLAND CEMENT CHITOSAN ON 
DENTINOGENIC/OSTEOGENIC DIFFERENTIATION OF STEM CELL 
FROM HUMAN EXFOLIATED DECIDUOUS TEETH 
ABSTRACT 
Mineral trioxide aggregate (MTA) is a recent gold standard endodontic biomaterial 
but its application is limited by expensive cost, long setting time and can cause 
cell toxicity. To overcome this problem, the discovery and development of new 
potential biomaterial is crucially required. Hence, in this study we determined the 
effects of 
accelerated Portland cement-chitosan (APC-CHT) on the dentinogenic and 
osteogenic differentiation in stem cells from human exfoliated deciduous teeth 
(SHED). The APC-CHT was prepared 1 week prior to the treatment on SHED for 14 
days. The cell 
morphology was accessed using an inverted microscope. SHED demonstrated 
phenotype transition from fibroblast-like to extended-spindle morphologies starting 
from Day 7 until Day 14. The highest protein concentration obtained through 
Bradford assay was 16.89 mg/ml which is in group 4 (APC-2.5 % CHT). The sizes 
of proteins 
in this study i.e. OCN, GAPDH, ALP, DMP-1, MEPE, OPN and DSPP were evaluated 
using SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE). The highest 
band intensity was observed in Day 14 in group 3 (APC-1.25 % CHT) and 4 
(APC-2.5 % 
CHT). Western blot analysis also demonstrated the appearance of apparent bands in 
Day 14 in both group 3 and 4. In conclusion, APC-CHT exhibited favourable effects 
on dentinogenic/osteogenic differentiation in SHED and has the potential to be used 
as an alternative material in dental applications. 
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CHAPTER 1  
INTRODUCTION 
 
1.1 Background of the study 
Dental diseases affect many people throughout their lives by causing pain, discomfort, 
disfigurement and even death. The Global Burden of Disease Study 2017 estimates 
that oral diseases affect approximately 3.5 billion people worldwide, with the most 
common condition being permanent teeth caries followed by periodontal diseases, oral 
cancers and dental trauma (WHO, 2020). The exposed teeth due to the diseases will 
allow pathogenic bacteria to enter the pulp chamber or root canals and cause severe 
endodontic infection. Several dental therapies, including dental implant and prosthesis 
are available but they fail to restore natural dentition even though they own excellent 
esthetic function. Hence, endodontic therapy is the treatment of choice since the goal 
of the therapy is to preserve the natural tooth as a functional unit within a functioning 
dentition (Yeng et al., 2007). The main challenge of endodontic therapy is that the 
existing endodontic biomaterials are limited by several drawbacks. Biomaterial such 
as calcium hydroxide has been widely used in dental therapy however, it was limited 
by poor seal and has no inherent adhesive qualities (Hilton, 2009). Mineral trioxide 
aggregate (MTA) is considered as an alternative to calcium hydroxide and recognized 
as a gold standard of dental biomaterial in endodontic therapy including root-end 
filling, pulp capping and pulpotomy for primary tooth. The material is a favourable 
substitute due to its anti-microbial properties, great biocompatibility, its regenerative 
effect for periodontal tissue and its ability to guide hard tissue formation (Naik et al., 




and damage. The long setting time of MTA also contributes to inconvenience in 
clinical use (Tsai et al., 2018).  
Therefore, these drawbacks make MTA not meet the clinical requirements; 
thus it is a priority to explore or develop new endodontic materials. Portland cement 
(PC), which is compositionally similar to MTA has been widely explored in several 
studies due to its lower costs and shorter setting time (Naiana et al., 2011). Regardless 
of the economic benefits, PC alone is not suitable for clinical applications due to a lack 
of radiopacity (Rahimi et al., 2019a). However, the lack of radiopacity of the PC makes 
it advantageous to reduce the toxicity effects of the cements (Coutinho-Filho et al., 
2008). 
In the present study, a new biomaterial consists of three main components, 
white Portland cement (WPC), calcium chloride dehydrate (CaCl2.H₂O) and chitosan 
(CHT) was synthesized and called accelerated Portland cement with chitosan (APC-
CHT). CaCl2.H₂O is a common accelerator used to shorten the setting time of PC (Oey 
et al., 2015) and the addition of CHT may enhance the functionality of the cement 
(Ustinova and Nikiforova, 2016). Chitosan is an applicable additive due to its 
remarkable properties such as great biocompatibility and biodegradability, excellent 
antibacterial property and able to promote cell attachment, proliferation and 
differentiation (Croisier and Jérôme, 2013). By integrating APC with chitosan, it 
results in combination of the non-toxic properties of the cement and antibacterial 
properties of the polymer. Thus, APC-CHT can be a promising substitute to MTA and 
other current dental materials. In this study, the synthesized material was investigated 
for its ability to induce the dentinogenic/osteogenic differentiation of SHED to form 




1.2 Problem statement 
Current good material like MTA is widely used in dental clinical setting, however, the 
functions are limited by causing some toxicity and requiring a longer period of setting 
time (Tsai et al., 2018). Due to some other limitations of common dental biomaterials, 
it leads to the emergence of new biomaterial design to restore defective tissue and, at 
the same time to guide the formation of new tissues during the therapy. Thus, the 
development of biomaterials that are non-toxic, possess antibacterial properties, 
promote the regeneration of new healthy tissues, enhance dental cell activity, low-cost, 
can be used under different climatic conditions, storage-tolerate and allow easy 
handling is indispensable (Deb and Chana, 2015). Therefore, the purpose of the study 
is to investigate the effects of newly synthesized material (APC-CHT) on dentinogenic 
and osteogenic differentiation ability of SHED. 
1.3 Rationale of the study 
Portland cement is a biocompatible material for dental application and the cement is 
safer, faster setting time and more economic substitute for MTA while chitosan is a 
natural polymer that own outstanding antibacterial property, biodegradable and 
considered as non-toxic material. Thus, CHT was incorporated into Portland cement 
to synthesize non-toxic biomaterial with the presence of bacteriostatic effects. The 
APC-CHT was developed and tested in the study to investigate the effect of the 
material on the differentiation of SHED into odontoblasts and osteoblasts for 
regeneration of tooth structure. The APC-CHT may be considered as a new competent 
biomaterial due to its biocompatibility, biodegradability and antibacterial properties. 
Therefore, the aim of the study is to determine the effects of APC-CHT seeded with 






1.4.1 General objective 
To study the effect of APC-CHT on dentinogenic/ osteogenic differentiation on SHED 
 
1.4.2 Specific objectives 
 
i. To determine the expression of dentinogenic protein (DMP-1, DSPP and MEPE)  
by Western blot  
ii. To determine the expression osteogenic protein (ALP, OCN and OPN) by Western 
blot 
 
1.5 Hypothesis  
 






CHAPTER 2  
LITERATURE REVIEW 
 
2.1 Dental diseases 
Tooth is the vital organ in human body where any defect has an effect on the quality 
of human life. Regardless of their importance, people are unconscious of the existence 
of hidden dangers that can be caused by dental defects. The lack of awareness among 
the public people can be seen through the high cases of dental caries and periodontal 
diseases.  It is estimated that 3.5 billion people have been affected not only by caries 
and gum problems but also by oral cancers, oral HIV manifestations, dental trauma, 
cleft lip and palate and noma  (Dye, 2017; WHO, 2020).  
Oral health is one of the major concerns by the government because it has a 
devastating health burden in many countries due to the fact that dental disease not only 
causes pain throughout human life but can also lead to disfigurement and death (Kaye, 
2007). Most dental pain occurs as a result of caries and once caries reaches dentine 
structure, the pain may occur in the presence of thermal stimulation or sweet-sour of 
dietary sources (Holt et al., 2001). Pain may also occur when dentine is exposed to 
trauma, erosion or abrasion. In addition, dental decay can provide pathogenic bacteria 
access into the root canal system and lead to endodontic infections including apical 
periodontitis (Persoon and Özok, 2017). 
Periodontitis can cause loss of tooth which is a common infirmity in the 
global population. The tooth loss often results in hard tissue damage of the jaw, 
creating an enormous clinical challenge for dental practitioners to solve the problems 
(Jimi et al., 2012). The most worrisome part is that a research study reported that 9 out 




by Ibrahim et al. (2020), all 46 chronic kidney disease (CKD) patients in Northeast 
Peninsular Malaysia tertiary hospital suffer periodontal problems  (Ibrahim et al., 
2020). These revealed that dental problems occur in both healthy and 
immunocompromised individuals, leading to an extra burden to be resolved.  
 
2.2 Treatments for dental diseases 
In oral disease, there are variety of treatments depending on the stage of the disease, 
ranging from non-surgical therapies that control bacterial growth to surgery for 
repairing the damaged tissues (Armitage and Robertson, 2009). In general, dental 
surgery are divided into three main components which are endodontic, prosthodontics 
and orthodontic. Endodontic is a type of surgery that deals with the root of tooth, 
prosthodontics is a surgery that involve dental prosthetics and orthodontic is a surgical 
treatment that involves of placing of devices on tooth structure to treat abnormalities 
(Thiti, 2017). In the surgery aspects, dental prosthesis and implant remain as 
conventional therapies (Garrett et al., 2004).  
Non-surgical therapy such as scaling and root planing (SRP) is known to be 
the gold standard for the initial treatment of inflammatory periodontal disease 
(Myneni, 2020). Non-surgical periodontal therapy involves patient managing oral 
home care on a daily basis for success in maintaining dental health yet the therapy 
tends to fail because it relates to patient compliance (Aimetti, 2014). A previous study 
mentioned that a high percentage of non-compliance problems contribute to the burden 
of managing dental hygiene (Lin et al., 2008). The therapy is intended to control 
microbial infection by removing bacterial biofilm, calculus and toxins from 
periodontally involved root surfaces. Even so, the treatment is limited by several 




the risk of disease recurrence. For tooth caries, a dental filling is used but the 
restoration often fails over time, mainly due to recurrent caries. The failure in 
restoration of tooth defects is a worrisome situation because of increasing cases of 
dental caries from year to year (Çolak et al., 2013). Thus, there is an immense need to 
develop a new generation of smart biomaterials to reduce and eliminate caries and 
other dental problems.  
 
2.3 Restorative and regenerative approach  
For a long time, restorative care has been primarily involved in treating tooth defects 
by simply filling the hole or replacing the missing tooth structure with a material 
without considering any good regenerative effects (Battistella et al., 2010). Previously, 
the main restorative goal of dentistry was only to remove decay and recently, the 
primary goal of dental restoration is not just about filling the infected cavity but also 
to place good biomaterials that will lead to regeneration of tissues and create an 
environment where tissues can heal (Manivasagam et al., 2018). As to circumvent the 
limitations of current therapies, regenerative dentistry approach using biomaterials 
have been proposed as an alternative to promote dental repair. In the literature, 
regenerative dentistry is usually referred to as a branch of regenerative medicine that 
focuses on the regeneration and repair of damaged oral tissues (Tran et al., 2019). The 
ultimate goal of the approach is to restore defects and regenerate new healthy tissues 
(Mardas et al., 2014). Because of these reasons, endodontic therapy has emerged as a 
promising approach to treat dental disorders. Endodontic therapy involves a series of 
treatments, including removal of pulpal tissue, filling and shaping root canals, 
obturation of the root canal space and placing a permanent restoration for the teeth 




process used to treat endodontic infection but several technical complications such as 
root perforations and failure in identifying all pulp ramifications contribute to the 
treatment failure. Thus, pulp capping is often practiced as an alternative to root canal 
therapy since it is easier to perform and allow direct inspection of the wound area 
(Komabayashi and Zhu, 2010). In endodontic therapy, the crucial key to successful 
therapy depends largely on the endodontic biomaterials.  
 
2.4 Biomaterial in dentistry  
The ideal dental biomaterial exhibits several outstanding properties such as 
biocompatible, biodegradable, promote cell and tissue formation, provide sufficient 
structural support and allow cell proliferation and differentiation for regeneration of 
dental tissues including enamel, dentin, cementum, bone and other intraoral tissues 
(Sharma et al., 2014). Biomaterials applications in dentistry are divided into four 
general categories which are polymers, ceramics, metals and composites 
(Abdolahpour et al., 2017). 
 
2.4.1 Polymers 
Polymers contribute significantly in different aspects of dentistry (e.g. preventive, 
restorative, regenerative) due to their outstanding physical, mechanical and biological 
properties. Besides, the materials are useful for dentin regeneration or advanced drug 
delivery systems (Rokaya et al., 2018). Over the last decade, polymers such as 
alginates, polysulfides and silicone have been widely used in impression materials, the 
material for construction of oral structures replica (Eichmiller, 2012). Natural-based 
polymers (e.g. starch, chitosan, collagen) and synthetic-based polymers (e.g. 




biodegradable materials in dental application such as in implants and suture (Prakasam 
et al., 2017). The biodegradable polymers are also used in restoration for the local 
release of bone stimulating or resorptive drugs in the peri-implant region in order to 
achieve long-term of dental implant success (Conte et al., 2018). 
 
2.4.2 Ceramics 
Excellent esthetic properties of ceramic have led the materials to be extensively used 
in dental restoration mainly as dental inlays, onlays, veneers, crowns and bridges 
(Höland et al., 2008). Dental ceramics reveal numerous desirable material properties, 
including biocompatibility, chemical inertness, abrasion proof and able to reduce 
plaque accumulation (Sarah and Richard van, 2009). The main components of dental 
ceramic are Silicon-based inorganic materials (e.g. feldspar, quartz, silica). The 
feldspar-based and quartz-based of ceramics are mainly used in prosthetic dentistry 
because they can mimic the various colours and shades of natural teeth (Ho and 
Matinlinna, 2011). Polycrystalline ceramics, such as yttria-stabilized zirconia, are 
commercially available for use as all-ceramic preformed crowns in pediatric 
applications (Platt, 2016). Since ceramics materials are incapable of withstanding 
functional forces present in the oral cavity, metal ceramic approach has emerged as an 
alternative. The idea of metal ceramic system is to combine the noble esthetic 
properties of ceramics with the excellent mechanical properties of metals. 
Unfortunately, some metals used in the restorative materials may affect patients 
through several adverse effects such as allergies, gum staining and gingivitis. These 
drawbacks urge researchers to return to metal-free ceramic systems in restoration and 





2.4.3 Metals  
Metallic biomaterials are well-known in hard tissue application including in field of 
dentistry. Metallic biomaterials exhibit unique structural functions, superior than 
ceramic and polymeric biomaterials and they have been employed extensively in 
substituting damage parts of human body (Peter et al., 2018). Among the bio-inert 
metallic materials, Titanium alloys, Cobalt and steel are well known in orthodontics 
and dental implant owing to their excellent lasting stability and reliable mechanical 
strength however long-term presence of the metals in the body is associated with an 
increased risk of development of cutaneous and systemic hypersensitivity reactions. 
(Prasad et al., 2017). 
 
2.4.4 Composites 
The term composites material is generally understood to mean a material consist from 
two or more constituent materials with different physical or chemical properties and 
the combination resulted in material with characteristics different from the individual 
components. Dental composites such as resin becomes one of several alternatives 
to dental amalgams due to their tooth-colored properties (Food and Drug 
Administration, 2017). Moreover, most of endodontic biomaterial are categorized 
under the composite group. The composite cement based on calcium silicate like 
Portland cement and mineral trioxide aggregate (MTA) are extensively used as a 
material in pulp capping and root canal-filling material. Both Portland cement and 
MTA able to result in remineralizing effects because of the presence of tricalcium and 






2.5 Current status of endodontic biomaterials 
Numerous biomaterials have been developed for endodontic application such as zinc 
oxide eugenol (ZOE), glass ionomer (GI), resin modified glass ionomer (RMGI), 
adhesive systems, calcium hydroxide, mineral trioxide aggregate (MTA) and 
biodentine (Moussa and Mostafa, 2018). Unfortunately, ZOE, GI, RMGI and adhesive 
system have been identified as cytotoxic materials towards dental pulp cells (Hilton, 
2009; Murray et al., 2002). Calcium hydroxide was introduced in 1921 and has been 
acknowledged as a gold standard of direct pulp capping materials for several decades, 
which was due to its outstanding antibacterial properties. Even so, the material cannot 
provide a proper seal and has insufficient adhesive qualities (Hilton, 2009). 
Consequently, MTA is used as an alternative to the calcium hydroxide. The clinical 
performance of MTA is more effective compared to calcium hydroxide, where MTA 
has been shown to have a higher success rate in maintaining long-term tooth vitality, 
able to enhance better dentinogenic process and inferior in causing pulpal 
inflammation. However, the antibacterial properties of MTA is debatable as the 
material exhibit the bactericidal effect only on facultative bacteria but no effect on any 
of the strictly anaerobic bacteria. It shows that bacteria suppression by MTA may not 
be as excellent as conventional calcium hydroxide (Moussa and Mostafa, 2018). In 
addition to the long setting time of MTA, which takes approximately 2 hours and 45 
minutes can expose the material to bacterial contamination therefore the procedure is 
inconvenient and impractical to both dentist and patient. Providentially, biodentine has 
been reported to have similar efficacy with MTA in direct capping application and it 
may be considered as a best substitute to MTA in human teeth (Mali and Mangala, 




(Kaur et al., 2017) and can cause significant leakage at the dentine-material interface 
(Malkondu et al., 2014). 
 
2.6 Potential biomaterial candidate: APC-CHT 
Since the current dental biomaterials are incapable to fulfil the clinical requirement 
and possessed several limitations, it leads to the urgency for the development of new 
ideal biomaterial. Additionally, the increased longevity of the population has elevated 
the demands for improved dental biomaterial function. The creation of new material 
consists of both restorative and regenerative properties is crucial. In the present study, 
APC-CHT were synthesized using three main components which are white Portland 
cement (PC), chitosan (CHT) and calcium chloride dehydrate (CaCl₂.H₂O). 
 
2.6.1 Portland cement (PC) 
Portland cement consists of calcium phosphate, calcium and silicon oxide and it has 
been effectively used as an apical plug material, perforation repair, root end filling 
material, pulp capping and pulpotomy in several studies. In point of fact, the main 
composition of MTA which is a current gold standard material  is 80% of PC along 
with the addition 20% of bismuth oxide (Naiana et al., 2011). The in vitro toxicity 
evaluation of bismuth oxide on various cell line type by Abudayyak et al. (2017) 
identified that the nanoparticles of the compund  resulted in high cell apoptosis and 
decreased the cell viability. The compound also able to trigger the induction of 
oxidative damage of cells (Abudayyak et al., 2017).  Due to the toxicity effects of 
bismuth oxide, many attempts had been initiated by many researchers to search for 




Moreover, Farhad Mollashahi et al. (2016) have conducted an in vitro study 
to determine the effect of PC on osteogenic/odontogenic differentiation of SCAP and 
they revealed that the cement was able to induce mineralization process and stimulated 
osteogenic and odontogenic differentiation (Farhad Mollashahi et al., 2016). A 
previous study reported that PC enriched with zirconium oxide and zinc oxide showed 
increase alkaline phosphatase activity and calcium ion release by DPSC which 
indicated the induction of osteo/odonto differentiation (Rahimi et al., 2019b). A case 
report on the application of white Portland cement as an apical plug in a tooth with a 
necrotic pulp and wide-open apex  revealed positive clinical resolution thus 
encouraged the use of WPC for root canal treatment (De-Deus and Coutinho-Filho, 
2007). 
Taking consideration of similar composition of MTA and PC, both of them 
exhibit similar effects in dental application. These materials produce a similar result 
in extracellular matrix neoformation by odontoblast cell line and formation of 
reparative dentin. In actual fact, PC is better than MTA because of inexpensive, shorter 
setting time and lesser toxicity towards dental cells (Naiana et al., 2011). The time 
reduction in setting time of PC is due to the addition of CaCl₂.H₂O, the common 
accelerator. CaCl₂ provides better compressive strength when added into tricalcium 
silicate cement in comparison with cement composite alone (Wang et al., 2008). From 
the industrial point of view, the process of biomaterial manufacturing must be simple, 






2.6.2 Chitosan (CHT) 
Chitosan is the second most abundant of natural polysaccharide that derived from 
deacytlated chitin which mainly found in the exoskeleton of crustaceans such as 
shrimp, crabs and lobsters (Cicciù et al., 2019). The polymer can be applied in all fields 
of dentistry including preventive dentistry, conservative dentistry, endodontics, 
surgery, periodontology, prosthodontics and orthodontics (Wieckiewicz et al., 2017).  
The purpose of chitosan addition in the present study is because of their 
significant properties such as antibacterial activity, mucoadhesive, haemostatic, 
biocompatible and biodegradable (Croisier and Jérôme, 2013). The chitosan-based 
materials have been explored broadly in dental applications since chitosan can easily 
blend with other materials (Husain et al., 2017). Chitosan has been added in several 
material developments such as glass ionomer cement, calcium hydroxide and it 
resulted in enhancement of antibacterial activity of the composites (Erpaçal et al., 
2019). The antibacterial activity of chitosan covers a broad spectrum of gram-negative 
and gram-positive bacteria as well as fungi. An in vitro study by Aliasghari et al. 
(2016) proved that chitosan is able to suppress the growth of cariogenic streptococci 
(Aliasghari et al., 2016). Moreover, another previous study suggested that the addition 
of chitosan to cement mortar increased the fungicidal effect because the polymer was 
able to suppress several types of oral fungi including Aspergillus spp. and Penicillium 
spp. that caused periodontitis (Ustinova and Nikiforova, 2016). Furthermore, Suzuki 
et al. (2014) reported in their study that chitosan enhanced the function of citrate 
solution as a root canal irrigant. Chitosan-citrate solution also  exhibited antibacterial 
effect against Enterococcus faecalis, one of the agent of endodontic infection  (Suzuki 




Several studies demonstrated the ability of chitosan to serve as a vehicle in 
oral drug delivery to dental structure like periodontal  tissue (Pichayakorn and 
Boonme, 2013; Qasim et al., 2017). Chitosan is also known as a hemostatic agent, thus 
the polymer render a benefit in invasive dental surgery that can cause bleeding 
disorders (Kmiec, 2017). In addition, chitosan was able to increase the regeneration 
capability of the dentin pulp complex and promoted osteogenesis in guided tissue 
regeneration (Erpaçal et al., 2019). The previous comparative study revealed that nano 
hydroxyapatite-chitosan cements have better bioactivity in comparison with MTA, 
calcium enriched mixture and hydroxyapatite (Hosseinzade et al., 2016). For these 
countless reasons, chitosan can be considered as a suitable choice to be an additive in 
the present study. 
 
2.7 SHED  
Human teeth become a rich source of mesenchymal stem cell (MSC) populations with 
high potential in dental studies. Dental stem cell types consist of dental pulp stem cells 
(DPSC), dental follicule stem cells (DFSC), stem cells from human exfoliated teeth 
(SHED), gingival fibroblastic stem cells (GFSC), stem cells from apical papilla 
(SCAP), periodontal ligament stem cells (PDLSC) and dental implant stem cells 
(DISC). Each of these dental MSC is named on the basis of the origin tissue (Figure 
1). Of these dental stem cells, SHED was selected for in the present study because of 
several important reasons. SHED was identified by Miura et al. (2003) as a highly 
proliferative and multipotent MSC that capable of differentiating into a variety of cell 
types including odontoblast and osteoblast (Miura et al., 2003). Numerous studies have 
demonstrated the ability of SHED in exhibiting dentinogenic and osteogenic properties 




dentin formation when injected to immune-deficient mice (Wang et al., 2018). Miura 
et al. (2003) also demonstrated that the regenerated dentin from SHED was immune-
reactive to dentin-specific antibody indicating that the cells can differentiate into 
odontoblasts in vivo (Miura et al., 2003). Since SHED are accessible with the least 
ethical concern, multi‐differentiation potentials and high proliferation rate, it will 










Figure 2.1 Dental stem cell. The name of dental MSC are depends on the extraction 
site which consist of dental pulp stem cells (DPSC), dental follicule 
stem cells (DFSC), stem cells from human exfoliated teeth (SHED), 
gingival fibroblastic stem cells (GFSC), stem cells from apical papilla 
(SCAP), periodontal ligament stem cells (PDLSC) and dental implant 





2.8 Protein expression analysis using Western blot 
The evaluation of dentinogenic and osteogenic differentiation of SHED is commonly 
performed by determining the expression of certain related markers. In this study, a 
several common markers such as alkaline phosphatase (ALP), dentin matrix acid 
phosphoprotein-1 (DMP-1), dentin sialophosphoprotein (DSPP), matrix extracellular 
phosphoglycoprotein (MEPE), osteocalcin (OCN), and osteopontin (OPN) were used 
for western blot analysis. DSPP, DMP1, and MEPE are dentinogenic markers while 
ALP, OCN and OPN are osteogenic marker, all of which play significant roles during 
proliferation and differentiation of cells (Ching et al., 2016). In Western blot, the 
isolation and purification of cell protein is used to determine the presence of protein in 
cell differentiation. The greatest advantage of the technique is its sensitivity in the 
protein detection as little as 0.1 nanograms of protein in the sample (National 
Diagnostics, 2011). The greater sensitivity, the fewer antibodies are required for 





CHAPTER 3  
MATERIALS AND METHODS 
 
3.1 Study design  
This study involved material preparation, cell culture technique and detection of 
protein expressions by Western blot assay. All the experimental works were carried 
out at the Advance Molecular Biology Laboratory, Craniofacial Science Laboratory 
and Culture Laboratory, at the Health Campus of Universiti Sains Malaysia. Flowchart 





















   
  
APC-CHT preparation 
Protein separation by using 10% SDS-PAGE 
APC-CHT treatment on SHED 
Quantification of protein bands by ImageJ software  
 
Culture and maintenance of SHED 
Estimation of protein concentration using Bradford protein assay 
Western blot analysis using dentinogenic/osteogenic specific primary 
antibodies 





3.2.1 Reagents and chemicals  
List of reagents and chemicals used in the study are listed in Table 3.1.  
 
Table 3.1 List of reagents and chemicals 
Item Manufacturer 
0.25% Trypsin-EDTA Gibco, USA 
2-mercaptoethanol Bio-Rad, USA 
30% Acrylamide Novus Biologicals, USA 
Absolute Ethyl Alcohol (Ethanol) HmbG, German 
Acetic acid Merck, Germany 
Ammonium persulfate Novus Biologicals, USA 
Bio-SafeTM Commasie G-250 Novus Biologicals, USA 
Calcium chloride dehydrate (CaCl₂.H₂O) Merck, Germany 
Chitosan Sigma-Aldrich, Iceland 
Clarity Western ECL Substrate Novus Biologicals, USA 
Dexamethasone Sigma-Aldrich, USA 
Dimethyl sulphoxide (DMSO) Merck, Germany 
Enhance chemiluminescence (ECL)  
plus western blotting detection reagents  
Amersham, USA 
 
Fetal bovine serum (FBS) Gibco, USA 
Glycine Amresco, USA 
L-ascorbic acid Sigma-Aldrich, USA 
Methanol Thermo Fisher Scientific, USA 
Penicillin-streptomycin Gibco, USA 
Phosphate-buffered saline (PBS) Gibco, USA 
Polyvinylidene difluoride (PVDF) Merck, USA 
Protease inhibitor Nacalai Tesque, Japan 
Resolving gel buffer  Bio-Rad, USA  
RIPA buffer  Amresco, USA  
Skimmed milk  Sunlac, Australia  
Sodium dodecyl sulfate (SDS)   Amresco, USA  




TEMED  Novus Biologicals, USA  
Trypan blue  Sigma-Aldrich, USA  
Tween-20 (T-20)  Amresco, USA  
White Portland Cement Aalborg, Malaysia 
α-Minimal Essential Medium (a-MEM)  Gibco, USA  






3.2.2 Antibodies  
Antibodies used in the study are listed in Table 3.2.  
 
Table 3.2 List of antibodies 








R & D Systems, USA 
Dentin matrix protein-1  
(DMP-1) 














Santa Cruz Biotechnology, 
USA 
Osteocalcin (OCN), Santa Cruz Biotechnology, 
USA 











3.2.3 Consumables  
List of consumables used in the study are listed in Table 3.3.  
 
Table 3.3 List of consumables 
Item Manufacturer 
0.20µm sterile filter PALL corporation, Life Sciences, USA 
1.5 ml microcentrifuge tubes Greiner bio-one, Austria 
75-cm2 flasks Biologix, China 
Disposable syringe Terumo Corporation, Japan 
Falcon Tube (15ml) Fisher Scientific, China 
Falcon Tube (50ml) Fisher Scientific, China 
Micro-centrifuge tubes (1.5ml) Labcon, USA 
Micro-centrifuge tubes (2ml) Labcon, USA 
Pipette tips Eppendorf 10µl, 20µl, 200µl 
and 1000µl 
Eppendorf AG, Germany 
Sterile serological pipette 10ml Greiner bio-one, Austria 
 
  
